Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood.
Functional assay of extrinsic (tissue-type) plasminogen activator (EPA) in plasma on fibrin plates was evaluated. Using specific quenching antibodies, we demonstrated the method to be specific for EPA under all conditions tested. Contributions of urokinases and intrinsic activators were excluded. The quantity of EPA in blood samples, as compared with purified uterine tissue activator, shows 1 blood activator unit (BAU) to be comparable to 0.93 ng. The median values for EPA activity for healthy volunteers were: baseline, 1.9 BAU/ml (n = 123); diurnal, 5.5 BAU/ml (n = 12); DDAVP administration, 11.7 BAU/ml (n = 39); exhaustive exercise, 25 BAU/ml (n = 24); venous occlusion (15 min), 35 BAU/ml (n = 61). A large inter-individual variation in EPA activity was found, while individual baseline values tended to be constant for periods of weeks. In vitro in blood EPA activity shows a disappearance of 50% in about 90 min at 37 degrees C; EPA activity in euglobulin fractions is stable for less than or equal to 2 hr at 37 degrees C. A rapid decrease in EPA activity occurs in vivo, as noted after extracorporal circulation and exercise stimulation (t1/2 decay, 2-5 min).
D000328:Adult; D002940:Circadian Rhythm; D003174:Complement C1 Inactivator Proteins / Q000494:pharmacology; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006207:Half-Life; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D010960:Plasminogen Activators / Q000032:analysis / Q000097:blood* / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood / Q000652:urine
D003174:Complement C1 Inactivator Proteins; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator; D003894:Deamino Arginine Vasopressin